Bionano Genomics, Inc.
BNGO
$1.14
-$0.03-2.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.71% | -24.04% | -121.02% | 84.59% | 54.52% |
| Total Depreciation and Amortization | -1.61% | -0.16% | -2.17% | 1.47% | -56.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.31% | -31.33% | 140.79% | -145.59% | -61.99% |
| Change in Net Operating Assets | 126.14% | -32.37% | -137.72% | -0.10% | 69.74% |
| Cash from Operations | 29.46% | -69.74% | -26.16% | 57.50% | 51.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 185.86% | -335.93% | 114.07% | -569.34% | 155.76% |
| Cash from Investing | 185.86% | -335.93% | 114.07% | -569.34% | 155.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.05% | -24.77% | -0.13% | 24.73% | -28.20% |
| Issuance of Common Stock | -86.47% | 318.60% | -76.80% | 98.24% | -33.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 86.58% | -831.73% | 88.68% | -12.35% | 67.54% |
| Cash from Financing | -84.09% | 585.91% | -86.51% | 179.97% | -35.39% |
| Foreign Exchange rate Adjustments | -53.33% | 162.50% | -166.67% | -125.00% | -116.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 390.54% | -688.89% | 98.94% | -1,669.39% | 103.00% |